Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Incisional Ketorolac in NSCLC and RCC
NCT04495894Phase 2Terminated
- Sponsor
- Emory University
- Start
- Aug 2020
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac in non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), sponsored by Emory University. Started Aug 2020; status: terminated.
02
Drugs
ketorolac
03
Conditions
non-small cell lung cancer (NSCLC)renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT04495894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495894.